Compare Eaton Corporation plc (ETN) vs Organon & Co. Common Stock (OGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eaton Corporation plc vs Organon & Co. Common Stock — how do they compare? Eaton Corporation plc trades at $405.46 (market cap $166.36B), while Organon & Co. Common Stock trades at $13.58 (market cap $3.62B). The key difference: Eaton Corporation plc is far larger — about 46× Organon & Co. Common Stock's market cap, and Eaton Corporation plc pays the higher dividend (1.03%). Which is the better fit depends on your goals — on Pluang, investors hold Eaton Corporation plc for 32 Days and Organon & Co. Common Stock for 0 Days on average.
| ETN | OGN | |
|---|---|---|
Market Cap | $166.36B | $3.62B |
Volume | 1,762,788 | 2,892,999 |
Sector | Industrials | Health |
52-Week High | $459.96 | $13.81 |
52-Week Low | $315.82 | $5.70 |
Typical Hold Time | 32 Days | 0 Days |
Enterprise Value | $186.99B | $11.04B |
Dividend Yield | 1.03% | 0.58% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Eaton (ETN) trades at $428.31, up 0.38% on the day, with a neutral technical signal and bullish moving averages. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Strong profitability is evident with a net income margin of 12.75% and ROE of 19.71%. Recent news highlights growth from data center and aerospace demand, supported by strategic acquisitions like COL Group (Business Wire, 2026-09-25).
The outlook remains positive given analyst consensus with a $502.38 price target and 70% buy ratings. Key opportunities include exposure to AI-driven data center expansion and grid modernization. Risks involve execution of acquisitions, competitive pressures, and macroeconomic sensitivity. Valuation multiples like a P/E of 43.62 suggest premium pricing relative to earnings growth.
Organon (OGN) trades at $13.77, showing no change in the latest session. The stock demonstrates strong profitability with 52.68% gross margins and 24.04% ROE, though recent quarterly earnings have missed expectations. Valuation appears reasonable with P/E of 17.65 and P/S of 0.59. The company shows positive cash flow trends with 2026 projections indicating $533M net cash flow. Recent FDA developments for MIUDELLA and VTAMA products highlight ongoing pipeline progress.
OGN presents a mixed outlook with solid fundamentals offset by earnings misses. The healthcare company's improving cash flow and product pipeline offer potential upside, but investor sentiment remains divided with analysts showing cautious optimism. Key risks include execution challenges and competitive pressures in the pharmaceutical sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eaton Corporation plc
Eaton is a global power management company providing energy-efficient solutions for electrical, aerospace, and industrial sectors. It focuses on improving sustainability through intelligent power technology.
Read more on ETN →About Organon & Co. Common Stock
Organon & Co. is a global healthcare company focused on women's health, biosimilars, and established brands, spun off from Merck & Co. in 2021. Its portfolio of more than 70 medicines includes contraception and fertility therapies, immunology and oncology biosimilars, and treatments in cardiovascular, respiratory, and dermatology, distributed in over 140 countries.
Read more on OGN →
